Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 186.386.905.456.3917101.11
AnnualDec 175.966.485.366.0522130.62
AnnualDec 165.255.405.095.2120130.50
QuarterlyJun 161.171.221.021.182101-0.32
QuarterlySep 161.401.501.301.4018100.76
QuarterlyDec 161.451.511.361.4718111.08
QuarterlyMar 171.521.521.521.521000.00
Long Term Growth 5.228.000.705.89501-15.86
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 155.425.44-0.38
QuarterlyJun 151.431.319.25
QuarterlySep 151.351.285.26
QuarterlyDec 151.281.29-0.74
QuarterlyMar 161.201.172.83
AnnualDec 145.075.07-0.01
AnnualDec 135.014.980.60
P/E Ratios
PeriodP/E Ratio
FY09.48
FY19.79
FY28.62
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY0-3.213.750.933
FY2/FY113.6211.031.023
FY3/FY27.074.781.022
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.